Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

260 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 3, 2026Sep 3 8:32 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$482.03$4.0M45,172(D)

View →

Sep 2, 2026Sep 3 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$493.46$4.7M324,443(I)

View →

Sep 3, 2026Sep 3 8:01 PMPAUL MAHON
Proposed Sale
8,300$482.03$4.0M—

View →

Sep 1, 2026Sep 2 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$514.09$4.9M324,443(I)

View →

Sep 1, 2026Sep 1 8:54 PMMARTINE ROTHBLATT
Proposed Sale
199,500$510.38$101.8M—

View →

Aug 31, 2026Sep 1 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$511.09$4.9M324,443(I)

View →

Aug 28, 2026Aug 31 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$517.51$4.9M324,443(I)

View →

Aug 27, 2026Aug 28 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$522.57$5.0M324,443(I)

View →

Aug 26, 2026Aug 27 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$517.28$4.9M324,443(I)

View →

Aug 25, 2026Aug 26 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$517.71$4.9M324,443(I)

View →

Aug 24, 2026Aug 25 8:38 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$511.97$4.9M324,443(I)

View →

Aug 21, 2026Aug 24 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$518.39$4.9M324,443(I)

View →

Aug 20, 2026Aug 21 8:44 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$521.02$4.9M324,443(I)

View →

Aug 20, 2026Aug 21 8:43 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$523.14$4.3M45,172(D)

View →

Aug 20, 2026Aug 20 10:45 PMPAUL MAHON
Proposed Sale
8,300$523.14$4.3M—

View →

Aug 19, 2026Aug 20 8:37 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$526.96$5.0M324,443(I)

View →

Aug 18, 2026Aug 19 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$515.60$4.9M324,443(I)

View →

Aug 17, 2026Aug 18 8:31 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$506.59$4.8M324,443(I)

View →

Aug 14, 2026Aug 17 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$498.91$4.7M324,443(I)

View →

Aug 13, 2026Aug 14 8:41 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$504.24$4.8M324,443(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →

Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,220—1,220(D)

View →

← Previous

Page 13 of 13